semaglutide and optic neuropathy A new study suggests patients taking — the active ingredient in Ozempic Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Anterior optic nerve neuropathy and

More research is expected to make retatroptide easier to use and give people with complicated metabolic health problems a lot of benefits

Understanding why a patient may respond differently to non-GLP-1 agents requires evaluating both clinical factors and underlying metabolic markers

While some patients report improvements in skin clarity or texture after B12 shots, these changes are usually most noticeable when a deficiency existed beforehand

Food and Drug Administration (FDA) Medication Errors Related to Unit of Measure: (Highlights the safety importance of units vs

Shotsy Shotsy is a clean, easy-to-use GLP-1 shot tracker with easy-to-understand charts and interface

In a pre-specified blinded extension for those with a BMI 35, participants who continued on retatrutide 12 mg to 104 weeks lost an average of 85.0 lbs (30.3%).2 Additionally, retatrutide showed significant improvements from baseline across certain cardiovascular risk factors, including waist circumference, non-HDL cholesterol, triglycerides, systolic blood pressure and high-sensitivity C-reactive protein (hsCRP)